Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDNQ   US24823Q1076

DENDREON CORPORATION (DNDNQ)

22
Delayed Quote. Delayed Nasdaq - 05/28 03:53:31 pm
0.03115 USD   -2.35%
02/20DJValeant Approved to Buy Dendreon Assets for $495 Million
02/20 Drugmaker Valeant close to buying Salix - source
02/12 VALEANT SECURES : Bloomberg
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/21/2015 05/22/2015 05/26/2015 05/27/2015 05/28/2015 Date
0.032(c) 0.0305(c) 0.032(c) 0.0319(c) 0.03115(c) Last
233 116 91 621 302 614 255 320 344 973 Volume
+1.59% -4.69% +4.92% -0.31% -2.35% Change
More quotes
Financials ($)
Sales 2014 299 M
EBIT 2014 -57,0 M
Net income 2014 -107 M
Debt 2014 -
Yield 2014 -
Sales 2015 327 M
EBIT 2015 -56,8 M
Net income 2015 -73,1 M
Debt 2015 421 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 0,02x
EV / Sales 2015 1,30x
Capitalization 5,06 M
More Financials
Company
Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients.The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular... 
More about the company
Surperformance© ratings of Dendreon Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on DENDREON CORPORATION
05/21 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
04/29 DENDREON : Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results
04/21 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
04/17 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
04/08 DENDREON : Other Events (form 8-K)
03/25 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
03/11 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
03/06 DENDREON : Other Events, Financial Statements and Exhibits (form 8-K)
More news
Sector news : Biotechnology & Medical Research - NEC
04:10p MEDIVATION : Names Andrew Powell General Counsel
04:04p ALNYLAM PHARMACEUTICALS : to Webcast Presentations at Upcoming June Investor Con..
04:01p ISIS PHARMACEUTICALS : Webcast Alert: Akcea Therapeutics Conference Call
More sector news : Biotechnology & Medical Research - NEC
Comments 
Advertisement
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDNQ | US24823Q1076 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions